64x Bio
Enabling next generation medicines. A comprehensive platform and…
64x Bio is active in the healthcare space based in San Francisco, CA, USA, founded in 2017.
Profile
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up.
Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.
Its activity falls under healthcare; the profile below is assembled from public directory data.
Its base of operations is San Francisco, CA, USA.
It is recorded at the Summer 2018 stage.
The company reports a headcount in the 25 range.
Total disclosed funding stands at about $59.5M.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Founded | 2017 |
| Employees | 25 |
| Stage | Summer 2018 |
| Total funding | $59,500,000 |
Website: www.64xbio.com
Browse related
Create a free account